Infiltrating ductal carcinoma
Showing 1 - 25 of 9,375
Infiltrating Duct Carcinoma of the Breast
Not yet recruiting
- Invasive Breast Cancer
- (no location specified)
Jan 28, 2023
Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)
Recruiting
- Atypical Ductal Hyperplasia
- Ductal Carcinoma in Situ
- Vacuum-assisted excisional biopsy
-
Milan, ItalyBreast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023
Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active
Completed
- Ductal Carcinoma in Situ
- Decision Support Tool with Active Monitoring
- Decision Support Tool without Active Monitoring
-
Durham, North CarolinaDuke Mammography Clinic
Jan 4, 2023
Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating
Recruiting
- Urothelial Carcinoma
- Non-Invasive Bladder Urothelial Carcinoma
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
-
Tampa, FloridaMoffitt Cancer Center
Mar 2, 2023
Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy
Completed
- Ductal Carcinoma in Situ
- Mastectomy with sentinel lymph node biopsy
- (no location specified)
Jul 17, 2023
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48）
- +3 more
- (no location specified)
Jun 9, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +5 more
- Intraoperative Imaging
- Lumpectomy
-
Chicago, Illinois
- +3 more
Nov 30, 2022
Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)
Not yet recruiting
- Non-Small-Cell Lung Carcinoma
- +2 more
- Liquid biopsy
- (no location specified)
Jan 24, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)
Completed
- Carcinoma, Pancreatic Ductal
- SonoVue
- Chemotherapy
-
Trondheim, NorwayDepartment of Radiology, St Olavs Hospital
Jan 17, 2023
Carcinoma, Ductal, Breast, Invasive Breast Cancer, IMAGE Trial in Seoul (contrast-enhanced breast MRI)
Completed
- Carcinoma, Ductal, Breast
- +2 more
- contrast-enhanced breast MRI
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Feb 25, 2022
PDAC - Pancreatic Ductal Adenocarcinoma, FAP Trial in New York ([68Ga]FAPI-46)
Recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- FAP
-
New York, New YorkNYU Langone Health
May 3, 2022
Ductal Breast Carcinoma in Situ Trial in Stanford (Lumpectomy, Partial breast irradiation prior to surgery)
Recruiting
- Ductal Breast Carcinoma in Situ
- Lumpectomy
- Partial breast irradiation prior to surgery
-
Stanford, CaliforniaStanford University
Jan 3, 2022
PDAC Trial in Beijing (68Ga-FAPI Positron Emission Tomography-Computed Tomography)
Recruiting
- PDAC
- 68Ga-FAPI Positron Emission Tomography-Computed Tomography
-
Beijing, Beijing, ChinaPeking Union Medical College Hospita
Mar 2, 2022
Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Tumor-infiltrating Lymphocytes (TIL)
- +5 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 28, 2022
Contrast-Enhanced MRI for Characterization of Ductal Carcinoma
Recruiting
- Breast Cancer
- contrast-enhanced magnetic resonance imaging
- Gadavist
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 30, 2021
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
MRI Characterization of Mammographically Detected DCIS
Recruiting
- Breast Cancer, Stage 0
- Breast MRI
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2022
Selective Extended Dissection in Different Types of Pancreatic
Completed
- Carcinoma, Pancreatic Ductal
- Selective extended dissection of pancreaticoduodenectomy
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Feb 9, 2023
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Predictive Factors for Resection and Survival in Type A
Not yet recruiting
- Carcinoma, Pancreatic Ductal
- Resection
- No Resection
- (no location specified)
Aug 3, 2022
Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in
Recruiting
- DCIS
-
Victoria, British Columbia, Canada
- +9 more
Jan 31, 2023